Download PDF
Osteosynthesis and Trauma Care 2003; 11(2): 88-94
DOI: 10.1055/s-2003-42518
Original Article

© Georg Thieme Verlag Stuttgart · New York

Immunolocalization of Osteogenic Protein-1 (OP-1, BMP-7) in Vasculature during Early Human Fracture Repair

M. F. Termaat1 , T. J. Blokhuis1 , D. Rueger2 , F. C. Bakker1 , P. Patka1 , E. H. Burger3 , H. J. Th. M. Haarman1 , A. L. J. J. Bronckers3
  • 1Department of Surgery/Traumatology, VU University Medical Center, Amsterdam, The Netherlands
  • 2Stryker Biotech, Hopkinton, MA, USA
  • 3ACTA/Oral Cell Biology, Vrije Universiteit, Amsterdam, The Netherlands
Further Information

Publication History

Publication Date:
06 October 2003 (online)

    Permissions and Reprints

Abstract

The osteoinductive capacities of bone morphogenetic proteins (BMPs) have extensively been described in animal models. Still little is known of their role in human fracture healing. In this study, localization of endogenous OP-1, BMP-7, during early human fracture repair was investigated, as this provides insight in the physiology of BMPs during fracture healing. The localization pattern of OP-1 was studied in bone and periosteum during fresh fracture healing. Nine patients with fractures requiring operative treatment were included. All biopsies were immunohistochemically analyzed for the localization of OP-1 with four different antibodies. In all biopsies positive staining was demonstrated in osteogenic cells, various cells in fibrous tissue, and in walls of vascular structures. The staining of vascular structures was confirmed by immunostaining with Ulex europaeus agglutinin I and smooth muscle cell actin for endothelial and smooth muscle cells, respectively. Thus, OP-1 contributes not only to fracture repair by enhancing the differentiation of osteogenic cells, but also may have an angiogenic role during human fracture repair.

Key words

Angiogenesis - immunohistochemical - human - BMPs

References

  • 1 Blokhuis T J, Boer d FC, Bramer J AM. et al . Biomechanical and histological aspects of fracture healing, stimulated with Osteogenic Protein-1.  Biomaterials. 2001;  22 725-730
    CrossrefPubMedGoogle Scholar
  • 2 Bostrom K, Watson K E, Horn S, Wortham C, Herman I M, Demer L L. Bone morphogenetic protein expression in human atherosclerotic lesions.  J Clin Invest. 1993;  91 1800-1809
    PubMedGoogle Scholar
  • 3 Bostrom M P, Lane J M, Berberian W S. et al . Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing.  J Orthop Res. 1995;  13 357-367
    PubMedGoogle Scholar
  • 4 Bouletreau P J, Warren S M, Spector J A. et al . Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing.  Plast Reconstr Surg. 2002;  109 2384-2397
    PubMedGoogle Scholar
  • 5 Brighton C T, Hunt R M. Early histological and ultrastructural changes in medullary fracture callus.  J Bone Joint Surg Am. 1991;  73 832-847
    PubMedGoogle Scholar
  • 6 Brownlow H C, Reed A, Simpson A H. The vascularity of atrophic non-unions.  Injury. 2002;  33 145-150
    CrossrefPubMedGoogle Scholar
  • 7 Cho T J, Gerstenfeld L C, Einhorn T A. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing.  J Bone Miner Res. 2002;  17 513-520
    CrossrefPubMedGoogle Scholar
  • 8 Choi I H, Ahn J H, Chung C Y, Cho T J. Vascular proliferation and blood supply during distraction osteogenesis: a scanning electron microscopic observation.  J Orthop Res. 2000;  18 698-705
    CrossrefPubMedGoogle Scholar
  • 9 Collin-Osdoby P. Role of vascular endothelial cells in bone biology.  J Cell Biochem. 1994;  55 304-309
    CrossrefPubMedGoogle Scholar
  • 10 Cook S D, Baffes G C, Wolfe M W, Sampath T K, Rueger D C. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop 1994; 302 - 312
    Google Scholar
  • 11 Cook S D, Rueger D C. Osteogenic protein-1: biology and applications. Clin Orthop 1996; 29 - 38
    Google Scholar
  • 12 Cook S D, Wolfe M W, Salkeld S L, Rueger D C. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates.  J Bone Joint Surg Am. 1995;  77 734-750
    PubMedGoogle Scholar
  • 13 Decker B, Bartels H, Decker S. Relationships between endothelial cells, pericytes, and osteoblasts during bone formation in the sheep femur following implantation of tricalciumphosphate-ceramic.  Anat Rec. 1995;  242 310-320
    PubMedGoogle Scholar
  • 14 Friedlaender G E, Perry C R, Cole J D. et al . Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions.  J Bone Joint Surg Am. 2001;  83A Suppl 1 151-158
    PubMedGoogle Scholar
  • 15 Geesink R G, Hoefnagels N H, Bulstra S K. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect.  J Bone Joint Surg Br. 1999;  81 710-718
    PubMedGoogle Scholar
  • 16 Glienke J, Schmitt A O, Pilarsky C. et al . Differential gene expression by endothelial cells in distinct angiogenic states.  Eur J Biochem. 2000;  267 2820-2830
    CrossrefPubMedGoogle Scholar
  • 17 Glowacki J. Angiogenesis in fracture repair. Clin Orthop 1998; S82 -S 89
    Google Scholar
  • 18 Goad D L, Rubin J, Wang H, Tashjian A HJ, Patterson C. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I.  Endocrinology. 1996;  137 2262-2268
    CrossrefPubMedGoogle Scholar
  • 19 Griffith D L, Keck P C, Sampath T K, Rueger D C, Carlson W D. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily.  Proc Natl Acad Sci USA. 1996;  93 878-883
    CrossrefPubMedGoogle Scholar
  • 20 Harada S, Nagy J A, Sullivan K A. et al . Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts.  J Clin Invest. 1994;  93 2490-2496
    PubMedGoogle Scholar
  • 21 Helder M N, Karg H, Bervoets T J. et al . Bone morphogenetic protein-7 (osteogenic protein-1, OP-1) and tooth development.  J Dent Res. 1998;  77 545-554
    PubMedGoogle Scholar
  • 22 Ishidou Y, Kitajima I, Obama H. et al . Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation.  J Bone Miner Res. 1995;  10 1651-1659
    PubMedGoogle Scholar
  • 23 Itoh S, Itoh F, Goumans M J, ten Dijke P. Signaling of transforming growth factor-beta family members through Smad proteins.  Eur J Biochem. 2000;  267 6954-6967
    CrossrefPubMedGoogle Scholar
  • 24 Kawabata M, Imamura T, Inoue H. et al . Intracellular signaling of the TGF-beta superfamily by Smad proteins.  Ann NY Acad Sci. 1999;  886 73-82
    PubMedGoogle Scholar
  • 25 Kloen P, Doty S B, Gordon E, Rubel I F, Goumans M J, Helfet D L. Expression and activation of the BMP-signaling components in human fracture nonunions.  J Bone Joint Surg. 2002;  84 1909-1918
    PubMedGoogle Scholar
  • 26 Li G, Simpson A H, Kenwright J, Triffitt J T. Effect of lengthening rate on angiogenesis during distraction osteogenesis.  J Orthop Res. 1999;  17 362-367
    CrossrefPubMedGoogle Scholar
  • 27 Li W, Chen F, Nagarajan R P, Liu X, Chen Y. Characterization of the DNA-binding property of Smad5.  Biochem Biophys Res Commun. 2001;  286 1163-1169
    CrossrefPubMedGoogle Scholar
  • 28 Li W M, Huang W Q, Huang Y H, Jiang D Z, Wang Q R. Positive and negative hematopoietic cytokines produced by bone marrow endothelial cells.  Cytokine. 2000;  12 1017-1023
    CrossrefPubMedGoogle Scholar
  • 29 Miyazono K, ten Dijke P, Heldin C H. TGF-beta signaling by Smad proteins.  Adv Immunol. 2000;  75 115-157
    PubMedGoogle Scholar
  • 30 Nakase T, Nomura S, Yoshikawa H. et al . Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing.  J Bone Miner Res. 1994;  9 651-659
    PubMedGoogle Scholar
  • 31 Nissen N N, Polverini P J, Koch A E, Volin M V, Gamelli R L, DiPietro L A. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing.  Am J Pathol. 1998;  152 1445-1452
    PubMedGoogle Scholar
  • 32 Oni O O. The early stages of the repair of adult human diaphyseal fractures.  Injury. 1997;  28 521-525
    CrossrefPubMedGoogle Scholar
  • 33 Onishi T, Ishidou Y, Nagamine T. et al . Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats.  Bone. 1998;  22 605-612
    CrossrefPubMedGoogle Scholar
  • 34 Probst A, Spiegel H U. Cellular mechanisms of bone repair.  J Invest Surg. 1997;  10 77-86
    CrossrefPubMedGoogle Scholar
  • 35 Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers G L. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells.  Br J Haematol. 2001;  115 186-194
    CrossrefPubMedGoogle Scholar
  • 36 Ramoshebi L N, Ripamonti U. Osteogenic protein-1, a bone morphogenetic protein, induces angiogenesis in the chick chorioallantoic membrane and synergizes with basic fibroblast growth factor and transforming growth factor-beta1.  Anat Rec. 2000;  259 97-107
    PubMedGoogle Scholar
  • 37 Ripamonti U, van den Heever B, Sampath T K, Tucker M M, Rueger D C, Reddi A H. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7).  Growth Factors. 1996;  13 273-289
    PubMedGoogle Scholar
  • 38 Schluesener H J, Meyermann R. Immunolocalization of BMP-6, a novel TGF-beta-related cytokine, in normal and atherosclerotic smooth muscle cells.  Atherosclerosis. 1995;  113 153-156
    CrossrefPubMedGoogle Scholar
  • 39 Singer A J, Clark R A. Cutaneous wound healing.  N Engl J Med. 1999;  341 738-746
    CrossrefPubMedGoogle Scholar
  • 40 Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis.  J Leukoc Biol. 1994;  55 410-422
    PubMedGoogle Scholar
  • 41 Tamaki K, Souchelnytskyi S, Itoh S. et al . Intracellular signaling of osteogenic protein-1 through Smad5 activation.  J Cell Physiol. 1998;  177 355-363
    CrossrefPubMedGoogle Scholar
  • 42 Tsukada T, McNutt M A, Ross R, Gown A M. HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues.  Am J Pathol. 1987;  127 389-402
    PubMedGoogle Scholar
  • 43 von Bubnoff A, Cho K W. Intracellular BMP signaling regulation in vertebrates: pathway or network?.  Dev Biol. 2001;  239 1-14
    CrossrefPubMedGoogle Scholar
  • 44 Vukicevic S, Latin V, Chen P, Batorsky R, Reddi A H, Sampath T K. Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: high affinity binding to basement membranes.  Biochem Biophys Res Commun. 1994;  198 693-700
    CrossrefPubMedGoogle Scholar
  • 45 Yang X, Castilla L H, Xu X. et al . Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5.  Development. 1999;  126 1571-1580
    PubMedGoogle Scholar
  • 46 Yeh L C, Lee J C. Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells.  Mol Cell Endocrinol. 1999;  153 113-124
    CrossrefPubMedGoogle Scholar
  • 47 Zwijsen A, van Grunsven L A, Bosman E A. et al . Transforming growth factor beta signaling in vitro and in vivo: activin ligand-receptor interaction, Smad5 in vasculogenesis, and repression of target genes by the deltaEF1/ZEB-related SIP1 in the vertebrate embryo.  Mol Cell Endocrinol. 2001;  180 13-24
    CrossrefPubMedGoogle Scholar

Marco F. Termaat

Department of Surgery/Traumatology · VU University Medical Center

P.O. Box 70 57

1007 MB Amsterdam

The Netherlands

Phone: +31/2 04 44 02 68

Fax: +31/2 04 44 02 74

Email: mf.termaat@vumc.nl